Lotus Eye Hospital & Institute Ltd

LOTUSEYE
NSE· Healthcare
₹122.04
-0.53 (-0.43%)
Updated 11:27 am IST
52W Low · ₹70.8452W High · ₹147.00
Mid Range
Market Cap
₹259.16L Cr
Volume
10.3K
Prev Close
₹122.57
ISIN
INE947I01017

Orion Score

Fundamentals-based quality & risk · not a recommendation

37/100
Caution

Lotus Eye Hospital & Institute Ltd scores 37/100 (Caution) on the Orion Score — weak business quality (37), weak growth (49), weak balance-sheet safety (42) and rich valuation (12). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality
37
Growth
49
Safety
42
Value
12

Full Orion analysis

Risk checks

  • Profit converts to cash (CFO 2.1× PAT)
  • Low debt, comfortable interest cover
  • No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 4/9Altman Z Safe(5.79)Beneish M Clean(-3.05)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

85/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION
Low Debt
D/E 0.26x — lean balance sheet
QUALITY
Low Quality
ROCE -0.5% — poor capital efficiency
MOMENTUM
Neutral
RSI 51.5 — consolidating

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio
3,115.50
ROCE
-0.50%
ROE (1Y)
—
D/E Ratio
0.26x
OPM
-4.59%
TTM EPS
₹0.04
Dividend Yield
—
Qtrly Sales
₹13.61 Cr
Qtrly Profit
₹-0.32 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q4 2026₹13.61₹-0.32-4.6%₹-0.15
Q3 2026₹13.55₹-0.26-2.4%₹-0.13
Q2 2026₹13.04₹0.12-0.5%₹0.06
Q1 2026₹13.52₹0.544.9%₹0.26
Q4 2025₹11.51₹0.253.6%₹0.12

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2025₹48.6₹0.74₹4.741.1%
FY 2024₹47.24₹2.91₹7.846.2%
FY 2023₹45.98₹4.08₹8.7310.2%
FY 2022₹38.09₹2.98₹6.729.1%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
LOTUSEYE ★₹259 Cr3,115.50-0.50%—0.26x-4.59%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹88,228 Cr25.6412.55%9.93%0.21x15.11%
ASTERDM₹71,372 Cr108.608.93%10.07%0.46x13.98%
ABBOTINDIA₹59,615 Cr38.4236.14%34.46%0.04x27.01%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹69.57₹66.63₹63.19₹61.6
Equity₹60₹59.41₹57.58₹54.61
Total Debt₹3.43₹1.11₹0.67₹1.24
Cash₹2.01₹2.65₹3.6₹3.79
Net Debt————
Working Capital₹4.15₹7.68₹9.52₹7.11

Shareholding Pattern

Q1 FY2027

Promoter
71.94%
FII
0%
DII
0%
Public
28.06%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202771.94% ↑0% ↓0% ↓28.06% ↓
Q3 FY202640.66% ↑0.01% ↑0.02%59.31% ↓
Q2 FY202640.63% ↑0% ↓0.02%59.33% ↓
Q1 FY202640.39% ↑0.01% ↑0.02% ↓59.57% ↓
Q4 FY202540.22% ↑0%0.04%59.73% ↓
Q3 FY202540.14% ↑0%0.04% ↑59.82% ↓
Q2 FY202540.03% ↓0%0%59.97% ↑
Q1 FY202540.24%0%0%59.76%

Corporate Actions

No recent corporate actions

Analyse LOTUSEYE with Orion AI

Ask: "Is Lotus Eye Hospital & Institute Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Lotus Eye Hospital & Institute Ltd (LOTUSEYE) Stock

Lotus Eye Hospital & Institute Ltd is listed on the NSE under the Healthcare sector, Hospital industry. ISIN: INE947I01017. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.